Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Long-Term Debt Repayments (2016 - 2023)

Dexcom (DXCM) has disclosed Long-Term Debt Repayments for 6 consecutive years, with $136.8 million as the latest value for Q4 2023.

  • On a quarterly basis, Long-Term Debt Repayments changed N/A to $136.8 million in Q4 2023 year-over-year; TTM through Dec 2024 was $136.8 million, a 0.0% change, with the full-year FY2023 number at $787.3 million, changed N/A from a year prior.
  • Long-Term Debt Repayments was $136.8 million for Q4 2023 at Dexcom, up from $75.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $136.8 million in Q4 2023 to a low of $136.8 million in Q4 2023.